# Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia

> **NCT05631444** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle** · enrollment: 24 (actual)

## Conditions studied

- Chronic Limb-threatening Ischemia
- Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** Cell-based therapy

## Key facts

- **NCT ID:** NCT05631444
- **Lead sponsor:** Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2022-10-28
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05631444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05631444, "Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05631444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*